Analytical Tool - Prostate Cancer

BioSeeker Group AB
March 25, 2014
SKU: BIOS5221725
The World Market for Flow Cytometry in IVD Applications
6/16/2014 | published by: Kalorama Information
The World Market for Flow Cytometry in IVD Applications Flow cytometers are powerful reference lab instruments that are now an important component of advanced IVD labs in developed nations. They are advanced diagnostic  |  read more...
USD 1,995
Proteins in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
Proteins in Oncology Drug Pipeline Update 2014 This drug pipeline update covers proteins, excluding antibodies, as drugs for the treatment of cancer. There are today 326 companies plus partners developing 359 protein drugs in 667 developmental projects  |  read more...
USD 6,746
Conference Documentation: Immunogenicity
7/14/2014 | published by: SMI Publishing, Ltd
Conference Documentation: Immunogenicity SMi are launching an Immunogenicity Conference, a two day event designed to become the leaders’ favourite with an ever growing demand for biologic therapeutics in the Pharmaceutical Industry.  |  read more...
USD 788
Malignant Mesothelioma - Pipeline Review, H2 2014
7/15/2014 | published by: Global Markets Direct
Malignant Mesothelioma - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Malignant Mesothelioma - Pipeline Review, H2 2014’, provides an overview of the Malignant Mesothelioma’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Malignant  |  read more...
USD 2,000
Global Retinal Vein Occlusion Market : 2014-2018
7/23/2014 | published by: TechNavio - Infiniti Research Ltd.
Press Release TechNavio Announces the Publication of its Research Report - Global Retinal Vein Occlusion Market 2014-2018 TechNavio recognizes the following companies as the key players in the Global Retinal Vein Occlusion Market: Bayer AG, F. Hoffmann-La  |  read more...
USD 2,500
Lung Cancer Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
Lung Cancer Drug Pipeline Update 2014 Non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) comprises over 95% of all lung cancers. High unmet needs still persist for this tumor type and despite two  |  read more...
USD 6,746
mTOR Signaling Pathway in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
mTOR Signaling Pathway in Oncology Drug Pipeline Update 2014 The mammalian target of rapamycin (mTOR) is an intracellular kinase that controls the production of proteins through its regulation of translational machinery. mTOR-activated proteins promote several hallmarks  |  read more...
USD 6,746
NOD-like Receptor Signaling Pathway in Cancer Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
NOD-like Receptor Signaling Pathway in Cancer Drug Pipeline Update 2014 Specific families of pattern recognition receptors are responsible for detecting various pathogens and generating innate immune responses. The intracellular NOD-like receptor (NLR) family contains more than  |  read more...
USD 4,496
Nucleic Acid Therapies in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
Nucleic Acid Therapies in Oncology Drug Pipeline Update 2014 Nucleic acid therapies in oncology includes: Gene Therapy, DNA vaccine, Other DNA technologies, RNA Interference (RNAi), Small interfering RNA (siRNA), Antisense RNA and Ribozymes. There are today 229  |  read more...
USD 6,746
Androgen Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
Androgen Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014 The androgen receptor signaling pathway activates the SMAD signaling module. There are today 332 companies plus partners developing 441 Androgen Receptor drugs in 1457 developmental projects in  |  read more...
USD 6,746
 

SELECT A LICENSE

    Electronic Access
Global Site License Fulfilled by Publisher
  USD 11,625  
    Electronic Access
Single User Fulfilled by Publisher
  USD 4,650  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!